Broadview Ventures

Broadview Ventures is an impact investor with a narrow aim: to speed up promising technology for diagnosing and treating heart disease and stroke, using targeted investments. It holds a spread of companies across different technologies and works to get treatments in front of patients.

What Broadview Ventures offers

• Targeted investment — funding for early medical companies in cardiovascular care.
• Diagnostic technology — Cardiosense builds an AI platform and a non-invasive monitoring device called CardioTag, first aimed at congestive heart failure.
• Heart devices — Nyra Medical is developing a device for mitral regurgitation, and Puzzle Medical Devices is developing ModulHeart, a percutaneous pump for advanced heart failure.
• Stroke treatment — RapidPulse is working on an aspiration system for removing clots in acute ischaemic stroke.
• Drug development — Comanche Biopharma is developing an siRNA therapy for pre-eclampsia, and XII Medical is working on a minimally invasive technology.

Who it works with

Developers of medical devices, digital tools and therapies in heart disease and stroke.

Key facts

• Focus: Cardiovascular disease and stroke
• Portfolio: Cardiosense, Comanche Biopharma, Nyra Medical, Puzzle Medical Devices, RapidPulse, XII Medical